These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4157350)

  • 41. Insights into the mechanism of azithromycin interaction with an Escherichia coli functional ribosomal complex.
    Dinos GP; Michelinaki M; Kalpaxis DL
    Mol Pharmacol; 2001 Jun; 59(6):1441-5. PubMed ID: 11353804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross resistance of Escherichia coli B ribosomes to inhibition of the puromycin reaction by erythromycin, spiramycin and chloramphenicol.
    Cerná J; Rychlík I
    Biochim Biophys Acta; 1968 Apr; 157(2):436-8. PubMed ID: 4870247
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparative studies on the mechanism of action of lincomycin, streptomycin, and erythromycin.
    Igarashi K; Ishitsuka H; Kaji A
    Biochem Biophys Res Commun; 1969 Oct; 37(3):499-504. PubMed ID: 4900140
    [No Abstract]   [Full Text] [Related]  

  • 44. Binding of erythromycin to Escherichia coli ribosomes.
    Teraoka H
    J Antibiot (Tokyo); 1971 May; 24(5):302-9. PubMed ID: 4996450
    [No Abstract]   [Full Text] [Related]  

  • 45. Release of tRNA from ribosomes by a factor other than G factor.
    Ishitsuka H; Kaji A
    Proc Natl Acad Sci U S A; 1970 May; 66(1):168-73. PubMed ID: 4921327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ribosomes containing mutants of L4 ribosomal protein from Thermus thermophilus display multiple defects in ribosomal functions and sensitivity against erythromycin.
    Tsagkalia A; Leontiadou F; Xaplanteri MA; Papadopoulos G; Kalpaxis DL; Choli-Papadopoulou T
    RNA; 2005 Nov; 11(11):1633-9. PubMed ID: 16244130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding of erythromycin to Escherichia coli ribosomes.
    Tanaka K; Teraoka H
    Biochim Biophys Acta; 1966 Jan; 114(1):204-6. PubMed ID: 5327844
    [No Abstract]   [Full Text] [Related]  

  • 48. Fluorescence polarization method to characterize macrolide-ribosome interactions.
    Yan K; Hunt E; Berge J; May E; Copeland RA; Gontarek RR
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3367-72. PubMed ID: 16048949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erythromycin, a peptidyltransferase effector.
    Mao JC; Robishaw EE
    Biochemistry; 1972 Dec; 11(25):4864-72. PubMed ID: 4570249
    [No Abstract]   [Full Text] [Related]  

  • 50. Interaction between the erythromycin and chloramphenicol binding sites on the Escherichica coli ribosome.
    Langlois R; Cantor CR; Vince R; Pestka S
    Biochemistry; 1977 May; 16(11):2349-56. PubMed ID: 324517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of polypeptide synthesis in cell-free systems by virginiamycin S and erythromycin. Evidence for a common mode of action of type B synergimycins and 14-membered macrolides.
    Chinali G; Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1988 Jan; 949(1):71-8. PubMed ID: 3120788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversal of the inhibitory action of chloramphenicol on the ribosomal peptidyl transfer reaction by erythromycin.
    Teraoka H
    Biochim Biophys Acta; 1970 Aug; 213(2):535-7. PubMed ID: 4927497
    [No Abstract]   [Full Text] [Related]  

  • 53. [Interaction of E.coli ribosomes with chloramphenicol. Effect of protamine hydrochloride on binding of C14-chloramphenicol by ribosomes and antibiotic inhibition of polypeptide synthesis in acellular systems].
    Belousova II; Lishnevskaia EB; Tereshin IM
    Antibiotiki; 1973 May; 18(5):411-6. PubMed ID: 4592561
    [No Abstract]   [Full Text] [Related]  

  • 54. Modeling Interactions of Erythromycin Derivatives with Ribosomes.
    Shishkina AV; Makarova TM; Tereshchenkov AG; Makarov GI; Korshunova GA; Bogdanov AA
    Biochemistry (Mosc); 2015 Nov; 80(11):1500-7. PubMed ID: 26615442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erythromycin, roxithromycin, and clarithromycin: use of slow-binding kinetics to compare their in vitro interaction with a bacterial ribosomal complex active in peptide bond formation.
    Dinos GP; Connell SR; Nierhaus KH; Kalpaxis DL
    Mol Pharmacol; 2003 Mar; 63(3):617-23. PubMed ID: 12606769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonidentity of the site of action of erythromycin A and chloramphenicol on Bacillus subtilis ribosomes.
    Oleinick NL; Wilhelm JM; Corcoran JW
    Biochim Biophys Acta; 1968 Jan; 155(1):290-2. PubMed ID: 4967315
    [No Abstract]   [Full Text] [Related]  

  • 57. Lincosamide antibiotics stimulate dissociation of peptidyl-tRNA from ribosomes.
    Menninger JR; Coleman RA
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2027-9. PubMed ID: 8239627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cooperative functioning of 2 systems of protection against its own antibiotic in Str. erythreus 1571, a superproducer of erythromycin].
    Griaznova NS; Beliavskaia IV; Subbotina NA; Listvinova SN; Orlova NV
    Antibiotiki; 1982 Feb; 27(2):105-17. PubMed ID: 7065644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit.
    Parfait R; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1981 Jul; 654(2):236-41. PubMed ID: 6793070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotics as probes of ribosome structure: binding of chloramphenicol and erythromycin to polyribosomes; effect of other antibiotics.
    Pestka S
    Antimicrob Agents Chemother; 1974 Mar; 5(3):255-67. PubMed ID: 4599122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.